Voyager Therapeutics, Inc. Debt Securities, Available-for-sale, Noncurrent
Voyager Therapeutics, Inc. (VYGR) had Debt Securities, Available-for-sale, Noncurrent of $1.10 million as of 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2018-03-14
- 2017-12-31: Debt Securities, Available-for-sale, Noncurrent $1.10M.
- 2017-09-30: Debt Securities, Available-for-sale, Noncurrent $960.00K.
- 2017-06-30: Debt Securities, Available-for-sale, Noncurrent $1.48M.
- 2017-03-31: Debt Securities, Available-for-sale, Noncurrent $2.00M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2017-12-31 | $1.10M 10-K · filed 2018-03-14 |
| 2017-09-30 | $960.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $1.48M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.00M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $1.36M 10-K · filed 2018-03-14 |
| 2016-09-30 | $2.42M 10-Q · filed 2016-11-10 |
| 2015-12-31 | $30.01M 10-K · filed 2017-03-15 |
| 2015-09-30 | $52.92M 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |